These results, along with a prior report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 assistance the principle of concentrating on ACKR3 as a singular approach to modulate the opioid system, which could open new therapeutic avenues for opioid